A Summary Of Key IP-Related Actions Taken By The 70th World Health Assembly 31/05/2017 Catherine Saez After what was described as the biggest World Health Assembly ever, with the highest number of agenda items and the highest attendance, it seemed that all’s well that ends well at the closing ceremony earlier today. A notable fact during this assembly has been the rising volume of voices from developing countries, joined by developed countries on issues related to access to affordable, safe, and efficacious medicines. Resolutions and decisions were adopted, many with hopes of better addressing challenges such as antimicrobial resistance, cancer, substandard and falsified medical products, medicines access and shortages and more. Continue reading -> WHO Asked To Square Its Position On Herbicide; EU Evaluation Seen As Flawed 31/05/2017 Catherine Saez Does glyphosate, better known under its brand name RoundUp, increase the risk of cancer in humans, or not? Yesterday, some World Health Organization members, while hailing a draft resolution on cancer later adopted, underlined a lack of coordination on glysophate between the WHO and its agency for cancer research. Separately, a renowned scientist sent a letter to European Commission President, Jean-Claude Juncker, saying the evaluations on the herbicide are flawed, and should be done again to safeguard public health. Continue reading -> Challenges Remain For Worldwide Immunization By Vaccination 30/05/2017 Elise De Geyter Even though important milestones in the elimination of rubella and measles have been achieved worldwide, key challenges remain, presenters said during a technical briefing organised by the World Health Organization last week. Continue reading -> World Health Assembly Adopts Resolution To Fight Sepsis; Antimicrobial Resistance Major Threat 26/05/2017 Catherine Saez Antimicrobial resistance is a growing health concern as was acknowledged by countries at the World Health Assembly this week, and a resolution was adopted to fight sepsis, which is a life-threatening blood stream infection for which there is growing resistance. Continue reading -> Will The Money Keep Rolling?: Innovative Global Health Financing And Governance 26/05/2017 Mara Pillinger We are in a liminal moment for global health financing. The “golden age” of increasing donor funding is clearly over, arrested by the 2008 financial crisis. But while donor contributions are no longer climbing, they have not been falling, either. And it is possible this status quo will hold… But it’s equally possible that this is just the pause before the roller-coaster drops. Considering that Gavi, the Global Fund, and the World Bank will all be launching another replenishment round in 2019—and given the uncertainty surrounding US foreign aid commitments and post-polio financing—that drop may prove very steep indeed. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> Expanding Access To Medicines: What Role For Transparency? 25/05/2017 Mara Pillinger Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and Suerie Moon of the Graduate Institute Global Health Centre in Geneva point out, their details are rarely specified: transparency for what? Accountability to whom? On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into these questions at a panel co-sponsored by the Graduate Institute and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. Continue reading -> Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Asked To Square Its Position On Herbicide; EU Evaluation Seen As Flawed 31/05/2017 Catherine Saez Does glyphosate, better known under its brand name RoundUp, increase the risk of cancer in humans, or not? Yesterday, some World Health Organization members, while hailing a draft resolution on cancer later adopted, underlined a lack of coordination on glysophate between the WHO and its agency for cancer research. Separately, a renowned scientist sent a letter to European Commission President, Jean-Claude Juncker, saying the evaluations on the herbicide are flawed, and should be done again to safeguard public health. Continue reading -> Challenges Remain For Worldwide Immunization By Vaccination 30/05/2017 Elise De Geyter Even though important milestones in the elimination of rubella and measles have been achieved worldwide, key challenges remain, presenters said during a technical briefing organised by the World Health Organization last week. Continue reading -> World Health Assembly Adopts Resolution To Fight Sepsis; Antimicrobial Resistance Major Threat 26/05/2017 Catherine Saez Antimicrobial resistance is a growing health concern as was acknowledged by countries at the World Health Assembly this week, and a resolution was adopted to fight sepsis, which is a life-threatening blood stream infection for which there is growing resistance. Continue reading -> Will The Money Keep Rolling?: Innovative Global Health Financing And Governance 26/05/2017 Mara Pillinger We are in a liminal moment for global health financing. The “golden age” of increasing donor funding is clearly over, arrested by the 2008 financial crisis. But while donor contributions are no longer climbing, they have not been falling, either. And it is possible this status quo will hold… But it’s equally possible that this is just the pause before the roller-coaster drops. Considering that Gavi, the Global Fund, and the World Bank will all be launching another replenishment round in 2019—and given the uncertainty surrounding US foreign aid commitments and post-polio financing—that drop may prove very steep indeed. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> Expanding Access To Medicines: What Role For Transparency? 25/05/2017 Mara Pillinger Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and Suerie Moon of the Graduate Institute Global Health Centre in Geneva point out, their details are rarely specified: transparency for what? Accountability to whom? On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into these questions at a panel co-sponsored by the Graduate Institute and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. Continue reading -> Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Challenges Remain For Worldwide Immunization By Vaccination 30/05/2017 Elise De Geyter Even though important milestones in the elimination of rubella and measles have been achieved worldwide, key challenges remain, presenters said during a technical briefing organised by the World Health Organization last week. Continue reading -> World Health Assembly Adopts Resolution To Fight Sepsis; Antimicrobial Resistance Major Threat 26/05/2017 Catherine Saez Antimicrobial resistance is a growing health concern as was acknowledged by countries at the World Health Assembly this week, and a resolution was adopted to fight sepsis, which is a life-threatening blood stream infection for which there is growing resistance. Continue reading -> Will The Money Keep Rolling?: Innovative Global Health Financing And Governance 26/05/2017 Mara Pillinger We are in a liminal moment for global health financing. The “golden age” of increasing donor funding is clearly over, arrested by the 2008 financial crisis. But while donor contributions are no longer climbing, they have not been falling, either. And it is possible this status quo will hold… But it’s equally possible that this is just the pause before the roller-coaster drops. Considering that Gavi, the Global Fund, and the World Bank will all be launching another replenishment round in 2019—and given the uncertainty surrounding US foreign aid commitments and post-polio financing—that drop may prove very steep indeed. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> Expanding Access To Medicines: What Role For Transparency? 25/05/2017 Mara Pillinger Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and Suerie Moon of the Graduate Institute Global Health Centre in Geneva point out, their details are rarely specified: transparency for what? Accountability to whom? On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into these questions at a panel co-sponsored by the Graduate Institute and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. Continue reading -> Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Health Assembly Adopts Resolution To Fight Sepsis; Antimicrobial Resistance Major Threat 26/05/2017 Catherine Saez Antimicrobial resistance is a growing health concern as was acknowledged by countries at the World Health Assembly this week, and a resolution was adopted to fight sepsis, which is a life-threatening blood stream infection for which there is growing resistance. Continue reading -> Will The Money Keep Rolling?: Innovative Global Health Financing And Governance 26/05/2017 Mara Pillinger We are in a liminal moment for global health financing. The “golden age” of increasing donor funding is clearly over, arrested by the 2008 financial crisis. But while donor contributions are no longer climbing, they have not been falling, either. And it is possible this status quo will hold… But it’s equally possible that this is just the pause before the roller-coaster drops. Considering that Gavi, the Global Fund, and the World Bank will all be launching another replenishment round in 2019—and given the uncertainty surrounding US foreign aid commitments and post-polio financing—that drop may prove very steep indeed. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> Expanding Access To Medicines: What Role For Transparency? 25/05/2017 Mara Pillinger Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and Suerie Moon of the Graduate Institute Global Health Centre in Geneva point out, their details are rarely specified: transparency for what? Accountability to whom? On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into these questions at a panel co-sponsored by the Graduate Institute and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. Continue reading -> Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Will The Money Keep Rolling?: Innovative Global Health Financing And Governance 26/05/2017 Mara Pillinger We are in a liminal moment for global health financing. The “golden age” of increasing donor funding is clearly over, arrested by the 2008 financial crisis. But while donor contributions are no longer climbing, they have not been falling, either. And it is possible this status quo will hold… But it’s equally possible that this is just the pause before the roller-coaster drops. Considering that Gavi, the Global Fund, and the World Bank will all be launching another replenishment round in 2019—and given the uncertainty surrounding US foreign aid commitments and post-polio financing—that drop may prove very steep indeed. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> Expanding Access To Medicines: What Role For Transparency? 25/05/2017 Mara Pillinger Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and Suerie Moon of the Graduate Institute Global Health Centre in Geneva point out, their details are rarely specified: transparency for what? Accountability to whom? On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into these questions at a panel co-sponsored by the Graduate Institute and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. Continue reading -> Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> Expanding Access To Medicines: What Role For Transparency? 25/05/2017 Mara Pillinger Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and Suerie Moon of the Graduate Institute Global Health Centre in Geneva point out, their details are rarely specified: transparency for what? Accountability to whom? On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into these questions at a panel co-sponsored by the Graduate Institute and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. Continue reading -> Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New World Bank Report: World Unprepared To Face Next Inevitable Pandemic 25/05/2017 Catherine Saez A new report released today by the World Bank shows that the world is not quite prepared to face the next pandemic. As for many other issues, money, or rather the lack of it, is at the heart of the problem, according to the report, which provides 12 recommendations to tackle the issue at the country level. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> Expanding Access To Medicines: What Role For Transparency? 25/05/2017 Mara Pillinger Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and Suerie Moon of the Graduate Institute Global Health Centre in Geneva point out, their details are rarely specified: transparency for what? Accountability to whom? On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into these questions at a panel co-sponsored by the Graduate Institute and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. Continue reading -> Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> Expanding Access To Medicines: What Role For Transparency? 25/05/2017 Mara Pillinger Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and Suerie Moon of the Graduate Institute Global Health Centre in Geneva point out, their details are rarely specified: transparency for what? Accountability to whom? On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into these questions at a panel co-sponsored by the Graduate Institute and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. Continue reading -> Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Expanding Access To Medicines: What Role For Transparency? 25/05/2017 Mara Pillinger Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and Suerie Moon of the Graduate Institute Global Health Centre in Geneva point out, their details are rarely specified: transparency for what? Accountability to whom? On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into these questions at a panel co-sponsored by the Graduate Institute and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. Continue reading -> Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory 24/05/2017 William New In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines. Continue reading -> Posts navigation Older Posts Newer Posts